Pratik Shah's Net Worth
$53.5 Million
Who is Pratik Shah?
Pratik Shah has an estimated net worth of $53.5 Million. This is based on reported shares across multiple companies, which include Auspex Pharmaceuticals, Inc., Design Therapeutics, Inc., Synthorx, Inc., ARS Pharmaceuticals, Inc., and Ocera Therapeutics, Inc..
SEC CIK
Pratik Shah's CIK is 0001580787
Past Insider Trading and Trends
2023 was Pratik Shah's most active year for acquiring shares with 5 total transactions. Pratik Shah's most active month to acquire stocks was the month of January. 2015 was Pratik Shah's most active year for disposing of shares, totalling 4 transactions. Pratik Shah's most active month to dispose stocks was the month of April. 2013 saw Pratik Shah paying a total of $14,631,414.00 for 2,458,569 shares, this is the most they've acquired in one year. In 2020 Pratik Shah cashed out on 72,635 shares for a total of $4,812,414.80, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Auspex Pharmaceuticals, Inc. No price found
President and CEO
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -903.02K |
—
|
—
|
0
|
May 5
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 2
| |||
Form 4
| +0.93% | 8.33K |
$12.00 | $99,996.00 | 903.02K |
Feb 10
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Design Therapeutics, Inc. (DSGN) Snapshot price: $2.3
President, CEO and Chairperson
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Sep 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Feb 1
| |||
Form 4
| +519.69% | 129.92K |
$20.00 | $500,000.00 | 154.92K |
Mar 30
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Synthorx, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -100.00% | -62.41K |
$68.00 | -$4,244,016.00 |
0
|
Jan 23
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 7
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
ARS Pharmaceuticals, Inc. (SPRY) Snapshot price: $6.31
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 27
| |||
Form 4
|
∞
| 10.16M |
—
|
—
| 10.16M |
Nov 8
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Ocera Therapeutics, Inc. No price found
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Aug 30
| |||
Form 4/A
|
∞
| 2.44M |
$6.00 | $14,631,414.00 | 2.44M |
Feb 6 - Jul 15
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||